Literature DB >> 21689644

The diagnostic accuracy of the percentage of hypochromic red blood cells (%HYPOm) and cellular hemoglobin in reticulocytes (CHr) in differentiating iron deficiency anemia and anemia of chronic diseases.

Mari Rehu1, Susanna Ahonen, Kari Punnonen.   

Abstract

BACKGROUND: The percentages of hypochromic red blood cells (%HYPOm) and cellular hemoglobin in reticulocytes (CHr) are suggested to be useful screening markers of iron deficiency. The aim of this study was to investigate the diagnostic accuracy of %HYPOm and CHr in differentiating iron deficiency anemia (IDA) and anemia of chronic disease (ACD).
METHODS: The retrospective population consisted of 58 IDA patients, 129 ACD patients and 63 controls, on whom bone marrow examination and blood count with %HYPOm and CHr had been performed. Receiver operating characteristic (ROC) analyses with area under the ROC curves (AUC) were used as statistical tests.
RESULTS: AUCs for differentiating the groups using %HYPOm were as follows: IDA vs. controls 0.99, ACD vs. controls 0.85 and IDA vs. ACD 0.88. AUCs for CHr in distinguishing the groups were as follows: IDA vs. controls 0.95, ACD vs. controls 0.65 and IDA vs. ACD 0.83.
CONCLUSIONS: IDA and ACD patients were efficiently differentiated by using %HYPOm and CHr. Additionally, %HYPOm was higher and CHr was lower in IDA patients and in ACD patients than in controls. Thus, %HYPOm is higher and CHr is lower not only in absolute iron deficiency, but also when iron availability for erythropoiesis is restricted.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21689644     DOI: 10.1016/j.cca.2011.06.004

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Acute Inflammation and Metabolism.

Authors:  Miguel Lourenço Varela; Mihail Mogildea; Ignacio Moreno; Ana Lopes
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer.

Authors:  Ellinor I B Peerschke; Melissa S Pessin; Peter Maslak
Journal:  Am J Clin Pathol       Date:  2014-10       Impact factor: 2.493

Review 3.  Markers of iron status in chronic kidney disease.

Authors:  Adam E Gaweda
Journal:  Hemodial Int       Date:  2017-03-22       Impact factor: 1.812

4.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

5.  Evaluation of the Efficiency of the Reticulocyte Hemoglobin Content on Diagnosis for Iron Deficiency Anemia in Chinese Adults.

Authors:  Jie Cai; Meng Wu; Jie Ren; Yali Du; Zhangbiao Long; Guoxun Li; Bing Han; Lichen Yang
Journal:  Nutrients       Date:  2017-05-02       Impact factor: 5.717

6.  The effect of reticulocyte hemoglobin content on the diagnosis of iron deficiency anemia: A meta-analysis study.

Authors:  Merve Kılıç; Aysel Özpınar; Mustafa Serteser; Meltem Kilercik; Muhittin Serdar
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.